These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25985903)

  • 1. Correlates of Protection for Herpes Zoster Vaccine: Evaluating Candidate Immunological Variables.
    Dunning AJ
    J Infect Dis; 2015 Nov; 212(9):1521. PubMed ID: 25985903
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we promote vaccination against the herpes zoster virus?
    Rocha-de-Lossada C; Rocha-de-Lossada G; Rocha-de-Lossada M; Rocha-Bogas A
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Jun; 99(6):265-266. PubMed ID: 38593978
    [No Abstract]   [Full Text] [Related]  

  • 3. A new vaccine to prevent herpes zoster.
    Cohen JI
    N Engl J Med; 2015 May; 372(22):2149-50. PubMed ID: 25916342
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes Zoster Vaccine: Time for a Boost?
    Reddy KP
    J Gen Intern Med; 2017 Feb; 32(2):145-147. PubMed ID: 27730484
    [No Abstract]   [Full Text] [Related]  

  • 5. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies.
    Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T
    Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.
    Markus A; Lebenthal-Loinger I; Yang IH; Kinchington PR; Goldstein RS
    PLoS Pathog; 2015 Jun; 11(6):e1004885. PubMed ID: 26042814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis.
    Gilden D; Nagel M
    J Infect Dis; 2015 Jul; 212 Suppl 1(Suppl 1):S37-9. PubMed ID: 26116729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Prevention of Herpes Zoster Ocular Disease.
    Cohen EJ
    Cornea; 2015 Oct; 34 Suppl 10():S3-8. PubMed ID: 26114827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.
    Le Polain De Waroux O; Flasche S; Prieto-Merino D; Goldblatt D; Edmunds WJ
    Pediatr Infect Dis J; 2015 Aug; 34(8):858-64. PubMed ID: 26075814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.
    Leentjens J; Kox M; Stokman R; Gerretsen J; Diavatopoulos DA; van Crevel R; Rimmelzwaan GF; Pickkers P; Netea MG
    J Infect Dis; 2015 Dec; 212(12):1930-8. PubMed ID: 26071565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia.
    Imoto K; Okazaki A; Onishi F; Miyazaki Y; Okeda M; Yano S; Takao Y; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Iso H; Yamanishi K; Asada H;
    J Dermatol Sci; 2015 Sep; 79(3):235-40. PubMed ID: 26070505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One dose of HPV vaccine could prevent most cervical cancers, studies show.
    Mayor S
    BMJ; 2015 Jun; 350():h3198. PubMed ID: 26067838
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
    Schmied L; Terszowski G; Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Hess C; Stern M;
    Transplantation; 2015 Dec; 99(12):2651-5. PubMed ID: 26050016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012.
    Humes EA; Weinberger DM; Kudish KS; Hadler JL
    Open Forum Infect Dis; 2015 Jan; 2(1):ofv001. PubMed ID: 26034752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations.
    Wkly Epidemiol Rec; 2015 May; 90(22):261-78. PubMed ID: 26027016
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers.
    Findlow J; Bai X; Findlow H; Newton E; Kaczmarski E; Miller E; Borrow R
    Vaccine; 2015 Jun; 33(29):3322-30. PubMed ID: 26025807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaps in knowledge and prospects for research of adjuvanted vaccines.
    Seder R; Reed SG; O'Hagan D; Malyala P; D'Oro U; Laera D; Abrignani S; Cerundolo V; Steinman L; Bertholet S
    Vaccine; 2015 Jun; 33 Suppl 2():B40-3. PubMed ID: 26022566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.